Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis
Authors
Keywords
-
Journal
CELL DEATH AND DIFFERENTIATION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-07-06
DOI
10.1038/s41418-021-00817-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19
- (2021) Yun Kit Yeoh et al. GUT
- Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers
- (2021) François-Xavier Danlos et al. Cell Death & Disease
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
- (2020) Victor M Corman et al. Eurosurveillance
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
- (2020) Qun Li et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series
- (2020) Sigurd F. Lax et al. ANNALS OF INTERNAL MEDICINE
- Survival study of hospitalised patients with concurrent COVID‐19 and haematological malignancies
- (2020) Fernando Martín‐Moro et al. BRITISH JOURNAL OF HAEMATOLOGY
- SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues
- (2020) Carly G.K. Ziegler et al. CELL
- Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells
- (2020) Clarissa Campbell et al. NATURE
- Virological assessment of hospitalized patients with COVID-2019
- (2020) Roman Wölfel et al. NATURE
- Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot
- (2020) Sophie Amrane et al. Travel Medicine and Infectious Disease
- COVID-19 in patients with lung cancer
- (2020) J. Luo et al. ANNALS OF ONCOLOGY
- Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19
- (2020) Aymeric Silvin et al. CELL
- High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR
- (2020) Souad Assaad et al. EUROPEAN JOURNAL OF CANCER
- Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy
- (2020) Marie Helleberg et al. JOURNAL OF INFECTIOUS DISEASES
- COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
- (2020) Marina Chiara Garassino et al. LANCET ONCOLOGY
- COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis
- (2020) Robert Lorenz Chua et al. NATURE BIOTECHNOLOGY
- Determinants of COVID-19 disease severity in patients with cancer
- (2020) Elizabeth V. Robilotti et al. NATURE MEDICINE
- Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis
- (2020) Jean-Christophe Lagier et al. Travel Medicine and Infectious Disease
- Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
- (2020) Francesco Passamonti et al. Lancet Haematology
- Clinical outcomes of coronavirus disease 2019 (COVID‐19) in cancer patients with prior exposure to immune checkpoint inhibitors
- (2020) Qiuji Wu et al. Cancer Communications
- Association of Interleukin 7 Immunotherapy With Lymphocyte Counts Among Patients With Severe Coronavirus Disease 2019 (COVID-19)
- (2020) Pierre Francois Laterre et al. JAMA Network Open
- SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19
- (2020) Lars F. Westblade et al. CANCER CELL
- The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities
- (2020) Louis Maximilian Buja et al. CARDIOVASCULAR PATHOLOGY
- Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19
- (2020) Naoki Kaneko et al. CELL
- A dynamic COVID-19 immune signature includes associations with poor prognosis
- (2020) Adam G. Laing et al. NATURE MEDICINE
- Immune profiling of COVID-19 patients
- (2020) Priscilla N. Kelly SCIENCE
- Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans
- (2020) Prabhu S. Arunachalam et al. SCIENCE
- Impaired Cytotoxic CD8+ T Cell Response in Elderly COVID-19 Patients
- (2020) Jaana Westmeier et al. mBio
- Effect of Recombinant Human Granulocyte Colony–Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia
- (2020) Lin-ling Cheng et al. JAMA Internal Medicine
- Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer
- (2020) Victoria A. Avanzato et al. CELL
- Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
- (2020) Bina Choi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer
- (2020) Teresa Aydillo et al. NEW ENGLAND JOURNAL OF MEDICINE
- IgA dominates the early neutralizing antibody response to SARS-CoV-2
- (2020) Delphine Sterlin et al. Science Translational Medicine
- Epidemiology, Diagnosis, Treatment, and Prevention of Influenza Infection in Oncology Patients
- (2019) Razan El Ramahi et al. Journal of Oncology Practice
- Trust is good, control is better: technical considerations in blood microbiome analysis
- (2019) Robert Schierwagen et al. GUT
- Polyamines Control eIF5A Hypusination, TFEB Translation, and Autophagy to Reverse B Cell Senescence
- (2019) Hanlin Zhang et al. MOLECULAR CELL
- Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis
- (2019) Xinyang Song et al. NATURE
- Dimensionality reduction for visualizing single-cell data using UMAP
- (2018) Etienne Becht et al. NATURE BIOTECHNOLOGY
- Hepatic inflammation caused by dysregulated bile acid synthesis is reversible by butyrate supplementation
- (2017) Lili Sheng et al. JOURNAL OF PATHOLOGY
- Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
- (2017) Rudragouda Channappanavar et al. Seminars in Immunopathology
- Long-Term Shedding of Influenza Virus, Parainfluenza Virus, Respiratory Syncytial Virus and Nosocomial Epidemiology in Patients with Hematological Disorders
- (2016) Nicola Lehners et al. PLoS One
- Comprehensive description of blood microbiome from healthy donors assessed by 16S targeted metagenomic sequencing
- (2016) Sandrine Païssé et al. TRANSFUSION
- The Characterization of Novel Tissue Microbiota Using an Optimized 16S Metagenomic Sequencing Pipeline
- (2015) Jérôme Lluch et al. PLoS One
- Risk factors and containment of respiratory syncytial virus outbreak in a hematology and transplant unit
- (2013) N Lehners et al. BONE MARROW TRANSPLANTATION
- CD4 lymphopenia to identify end-of-life metastatic cancer patients
- (2012) Julien Péron et al. EUROPEAN JOURNAL OF CANCER
- Molecular Characterization of a Respiratory Syncytial Virus Outbreak in a Hematology Unit in Heidelberg, Germany
- (2012) Steffen Geis et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Human rhinovirus and coronavirus detection among allogeneic hematopoietic stem cell transplantation recipients
- (2009) F. Milano et al. BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now